Clinical trial on neridronate in Germany
Aachen. CRPS/Sudeck's disease was conducted by the pharmaceutical manufacturer Grünenthal, Aachen, to conduct a clinical study on the active ingredient neridronate. Neridronic acid) launched an aminobisphosphate. In various clinics in Germany, sufferers can take part in this clinical trial. The studies will be conducted at sites in the US, Canada, Germany, France, the UK, Spain, …